S285: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2-YEAR FOLLOW-UP FROM THE CARDINAL STUDY

Bibliographic Details
Main Authors: A. Röth, W. Barcellini, S. D’Sa, Y. Miyakawa, C. M. Broome, M. Michel, D. J. Kuter, B. Jilma, T. H. A. Tvedt, I. C. Weitz, T. Sourdille, J. Wang, D. S. Vagge, K. Kralova, F. Shafer, M. Wardecki, M. Lee, S. Berentsen
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000844032.88465.0b
_version_ 1797285952911048704
author A. Röth
W. Barcellini
S. D’Sa
Y. Miyakawa
C. M. Broome
M. Michel
D. J. Kuter
B. Jilma
T. H. A. Tvedt
I. C. Weitz
T. Sourdille
J. Wang
D. S. Vagge
K. Kralova
F. Shafer
M. Wardecki
M. Lee
S. Berentsen
author_facet A. Röth
W. Barcellini
S. D’Sa
Y. Miyakawa
C. M. Broome
M. Michel
D. J. Kuter
B. Jilma
T. H. A. Tvedt
I. C. Weitz
T. Sourdille
J. Wang
D. S. Vagge
K. Kralova
F. Shafer
M. Wardecki
M. Lee
S. Berentsen
author_sort A. Röth
collection DOAJ
first_indexed 2024-03-07T18:11:12Z
format Article
id doaj.art-a34cde245dfb45c88f1f16f61df2f2aa
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T18:11:12Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-a34cde245dfb45c88f1f16f61df2f2aa2024-03-02T07:47:14ZengWileyHemaSphere2572-92412022-06-01618618710.1097/01.HS9.0000844032.88465.0b202206003-00186S285: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2-YEAR FOLLOW-UP FROM THE CARDINAL STUDYA. Röth0W. Barcellini1S. D’Sa2Y. Miyakawa3C. M. Broome4M. Michel5D. J. Kuter6B. Jilma7T. H. A. Tvedt8I. C. Weitz9T. Sourdille10J. Wang11D. S. Vagge12K. Kralova13F. Shafer14M. Wardecki15M. Lee16S. Berentsen171 Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany2 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy3 UCLH Centre for Waldenström’s Macroglobulinemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, United Kingdom4 Thrombosis and Hemostasis Center, Saitama Medical University Hospital, Saitama, Japan5 Division of Hematology, MedStar Georgetown University Hospital, Washington DC, United States of America6 Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, UPEC, Créteil, France7 Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America8 Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria9 Section for Hematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway10 Keck School of Medicine of USC, Los Angeles, CA11 Sanofi, Cambridge, MA, United States of America11 Sanofi, Cambridge, MA, United States of America12 IQVIA, Bangalore, India13 Sanofi, Paris, France14 Sanofi, Bridgewater, NJ, United States of America15 Sanofi, Warsaw, Poland14 Sanofi, Bridgewater, NJ, United States of America16 Department of Research and Innovation, Haugesund Hospital, Haugesund, Norwayhttp://journals.lww.com/10.1097/01.HS9.0000844032.88465.0b
spellingShingle A. Röth
W. Barcellini
S. D’Sa
Y. Miyakawa
C. M. Broome
M. Michel
D. J. Kuter
B. Jilma
T. H. A. Tvedt
I. C. Weitz
T. Sourdille
J. Wang
D. S. Vagge
K. Kralova
F. Shafer
M. Wardecki
M. Lee
S. Berentsen
S285: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2-YEAR FOLLOW-UP FROM THE CARDINAL STUDY
HemaSphere
title S285: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2-YEAR FOLLOW-UP FROM THE CARDINAL STUDY
title_full S285: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2-YEAR FOLLOW-UP FROM THE CARDINAL STUDY
title_fullStr S285: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2-YEAR FOLLOW-UP FROM THE CARDINAL STUDY
title_full_unstemmed S285: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2-YEAR FOLLOW-UP FROM THE CARDINAL STUDY
title_short S285: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2-YEAR FOLLOW-UP FROM THE CARDINAL STUDY
title_sort s285 inhibition of complement c1s with sutimlimab in patients with cold agglutinin disease cad 2 year follow up from the cardinal study
url http://journals.lww.com/10.1097/01.HS9.0000844032.88465.0b
work_keys_str_mv AT aroth s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT wbarcellini s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT sdsa s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT ymiyakawa s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT cmbroome s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT mmichel s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT djkuter s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT bjilma s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT thatvedt s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT icweitz s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT tsourdille s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT jwang s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT dsvagge s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT kkralova s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT fshafer s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT mwardecki s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT mlee s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy
AT sberentsen s285inhibitionofcomplementc1swithsutimlimabinpatientswithcoldagglutinindiseasecad2yearfollowupfromthecardinalstudy